The mosquito project: a new and safe medical intelligent

Résumé du document

The goal of our group is to develop and to sell a new smart and secured medical system without hype. The system proposes an atomized injection for the treatment of an individual and which are possible at home. Indeed, elaborated injection systems, like pre-filled hype provoke a lot of needle accidents, for example in 2006, there were about 150,000 broken needles in France. However, 80% of accidents can be avoided by secured system. Medicine actors, pharmaceutical laboratories, doctors, nurses and patients are concerned by this problem. Our society is the solution thanks to the secured and automatic needle before, during and after injection. It allows to sting with precision, good depth and without pain. The product can be launched in 2011 if banks accept the idea and if we manage to convince them to give us money. One year is necessary to prepare and to develop strategies. This is why we will demonstrate the future success of our product.

Extraits

[...] Economical Opportunities - Government has a big debt due to medicine spending. The factor influences government to control medicine spending in decreasing cost and period in hospitals. In 2005, social insurance was 363,7 billion but spending were reached 400,2 billion. The debt was 5,4 billion. Strengths - Cost more expensive than hypes - Competitors less expensive Social Opportunities - People are more and more old in rich countries, that influence to develop new product concerning medicine. - People increasing and the improvement of standard of living in emerging countries. [...]

[...] Threats of new entrants It's low because the market of medicine and medical tools is hardly supervised. Entering this market needs”know-how” and a lot of money so it's quiet hard for a new company to introduce it. Furthermore, the DMI is protected by six certificates and is hard to imitate, that represent a big barer to the entry. Determinants of buyer power It's medium, because they have alternative to the DMI. Even if the product is new, they don't have the necessity to buy it, but it will improve the conditions to make injections. [...]

[...] Legal Opportunity - Juridical gap in injection system. Can we inject ourselves a product? It is an opportunity to launch this product. Market expectations Strengths Medical tools are always very controlled. We are expecting a certification for the product. Rubbish rate mustn't be upper 1%. We can't make a mistake in the production because we with life people. Risk is very high: one mistake and the product is forbidden so we have to be very careful about that, it's a main issue for us. [...]

[...] “Moskito” is a totally safety drugs injection system with unique features. Besides we keep close to our processes optimization competence, i.e. the more efficient industrialization of services, R&D or production processes, and the improvement of linkages between the two. Necessary resources Informational Patent Protection The right to use the idea and name or symbol of Moskito will be protected by the Patent and Trademark laws of the United States. The right conferred by the patent grant excludes others from making, using, offering for sale, or selling” the invention in the United States or “importing” the invention into the United States. [...]

[...] Then we will try to adapt the product to the final users, in order it fits to them the best as possible. The advantage of this type of innovation based on a customer's need is that we can really adapt it to the use to be more convenient and practical than others products. Thanks to that, the department of research and development now can start to develop their product according to what they describe before (stage 3). That's how they find this system of DMI ‘Moskito'. The product is now almost ready to be sold. [...]